K Number
K151033
Device Name
Philips Self-Adhesive Electrodes
Date Cleared
2015-07-28

(102 days)

Product Code
Regulation Number
882.1320
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Philips Self-Adhesive Electrodes are intended for use with the PulseRelief device for applying Transcutaneous Electrical Nerve Stimulation (TENS) and Electrical Muscle Stimulation (EMS)
Device Description
The Philips Self-Adhesive Electrodes is used as a transcutaneous electrical nerve stimulation electrode in conjunction with the Philips PulseRelief device which is an electrical stimulator for TENS or EMS. Electrodes are passive devices serving as an interface between a user's skin and a neurostimulation device. It is composed of: 1. Metal target, 2. Rivet, 3. Textile adhesive layer, 4. Carbon layer, 5. Hydrogel layer, 6. Backing sheet. Proper current distribution is delivered via use of a printed silver pattern.
More Information

Not Found

No
The device description and performance studies focus on the physical and electrical properties of passive electrodes, with no mention of AI or ML.

No
The device itself (electrodes) is a passive accessory that interfaces with a therapeutic device (Philips PulseRelief device) for TENS/EMS. The electrodes do not provide therapy on their own.

No
The device, Philips Self-Adhesive Electrodes, is an accessory used with a neurostimulation device (Philips PulseRelief) for applying TENS and EMS. It is described as a "passive device serving as an interface" and its purpose is to deliver electrical current, not to diagnose a condition.

No

The device description explicitly states it is composed of physical components (metal target, rivet, textile adhesive layer, carbon layer, hydrogel layer, backing sheet) and is a passive device serving as an interface, indicating it is a hardware component, not software.

Based on the provided information, the Philips Self-Adhesive Electrodes are not an IVD (In Vitro Diagnostic) device.

Here's why:

  • Intended Use: The intended use is for applying Transcutaneous Electrical Nerve Stimulation (TENS) and Electrical Muscle Stimulation (EMS) to the body. This is a therapeutic application, not a diagnostic one.
  • Device Description: The description details the components and function of the electrodes as an interface for electrical stimulation on the skin. It does not mention any analysis of biological samples (blood, urine, tissue, etc.), which is a key characteristic of IVD devices.
  • Performance Studies: The performance studies focus on the physical, electrical, and biocompatibility properties of the electrodes in contact with the skin, not on the accuracy or reliability of a diagnostic test.

IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Philips Self-Adhesive Electrodes do not perform this function.

N/A

Intended Use / Indications for Use

The Philips Self-Adhesive Electrodes are intended for use with the PulseRelief device for applying Transcutaneous Electrical Nerve Stimulation (TENS) and Electrical Muscle Stimulation (EMS).

Product codes

GXY

Device Description

The Philips Self-Adhesive Electrodes is used as a transcutaneous electrical nerve stimulation electrode in conjunction with the Philips PulseRelief device which is an electrical stimulator for TENS or EMS.
Electrodes are passive devices serving as an interface between a user's skin and a neurostimulation device.
It is composed of:

  1. Metal target
  2. Rivet
  3. Textile adhesive layer
  4. Carbon layer
  5. Hydrogel layer
  6. Backing sheet
    Proper current distribution is delivered via use of a printed silver pattern.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

The following performance data are provided in support of the substantial equivalence determination:
7.1 Biocompatibility testing
The biocompatibility evaluation for the Philips Self-Adhesive Electrodes device was conducted in accordance with the FDA Blue Book Memorandum #G95-1 "Use of International Standard ISO-10993, 'Biological Evaluation of Medical Devices Part 1: Evaluation and Testing," May 1, 1995, and International Standard ISO 10993-1 "Biological Evaluation of Medical Devices -Part 1: Evaluation and Testing Within a Risk Management Process," as recognized by FDA. As dictated by the application and duration of contact with the intact skin, the battery of testing included the following tests:
• Cytotoxicity
• Sensitization
• Irritation

7.2 Other Performance Tests
The Philips Self-Adhesive Electrode is the same as the predicate device, the ValuTrode® Neurostimulation Electrodes from Axelgaard and it is manufactured by Axelgaard. Therefore the tests performed in the Neurostimulation Electrodes applies to the Philips Self-Adhesive Electrode.

  1. Electrical & Impedance Tests: The Philips Self-Adhesive Electrode was tested to assure the current is equally distributed. The Philips Self-Adhesive Electrode was also tested for Impedance to assure proper electrical connection to the skin.
  2. Adhesion tests: The Philips Self-Adhesive Electrode was tested for initial adhesion force and adhesion force after using multiple times.
  3. Connector & Mechanical tests: The TENS PulseRelief has a magnetic surface with the purpose to clamp the Philips Self-Adhesive Electrode. This connection was tested to assure multiple use and also to assure the TENS PulseRelief stay fixed to the Philips Self-Adhesive Electrode during use.
  4. Packaging tests: The Philips Self-Adhesive Electrode was tested for storage conditions.
  5. Accelerated Aging: The Philips Self-Adhesive Electrode was tested for accelerate aging in worst storage condition to assure within the expiration date the electrode function as expected.

Key Metrics

Not Found

Predicate Device(s)

K130987

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 882.1320 Cutaneous electrode.

(a)
Identification. A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal features a stylized eagle with three heads, representing the department's commitment to health, human services, and science. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 28, 2015

Philips Consumer Lifestyle Marta Walker Sr. Safety, Compliance & Regulatory Manager 1600 Summer Street Stamford, Connecticut 06905

Re: K151033

Trade/Device Name: Philips Self-adhesive Electrodes Regulation Number: 21 CFR 882.1320 Regulation Name: Cutaneous Electrode Regulatory Class: Class II Product Code: GXY Dated: April 7, 2015 Received: April 17, 2015

Dear Marta Walker:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

1

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Carlos L. Pena -S 同Δ

Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Form Approved: OMB No. 0910-0120
Expiration Date: January 31, 2017
See PRA Statement below.

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Indications for Use

510(k) Number (if known)
Device NamePhilips Self-Adhesive Electrodes
Indications for Use (Describe)The Philips Self-Adhesive Electrodes are intended for use with the PulseRelief device for applying Transcutaneous Electrical Nerve Stimulation (TENS) and Electrical Muscle Stimulation (EMS)
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services

Food and Drug Administration

Office of Chief Information Officer

Paperwork Reduction Act (PRA) Staff

PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."

FORM FDA 3881 (8/14)

Page 1 of 1

PSC Publishing Services (101) 14-6740 EF

3

Department of Health and Human Services Centre of Device and Radiological Health Office of Device Evaluation Traditional 510(k) section

510(K) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION as required by section 21 CFR 807.92

1. SUBMITTER OF 510(K):

Company name:Philips Consumer Lifestyle
Registration number:3009181561
Address:1600 Summer Street
Stamford, CT 06905 USA
Phone:+31 6 319 78 546
emailmarta.walker@philips.com
Correspondent:Marta Walker,
Sr. Safety, Compliance & Regulatory
Date of Preparation:July 21st, 2015

2. DEVICE:

Trade/Proprietary Name:Philips Self-Adhesive Electrodes
Common/Usual Name:Electrodes
Regulation Name:Electrodes, Cutaneous
Classification Name:Neurological Diagnostic Devices
Classification:21CFR 882.1320 Class II
Product Code:GXY

3. PREDICATE DEVICE

Our new device is based on the legally marketed device cited in the table below:

ManufacturerDevice510(k) #
Axelgaard
Manufacturing Co.
LTD, 520 Industrial
Way, Fallbrook, CA
92028ValuTrode® Neurostimulation ElectrodesK130987

Table 1: Predicate device

4

4. DEVICE DESCRIPTION

The Philips Self-Adhesive Electrodes is used as a transcutaneous electrical nerve stimulation electrode in conjunction with the Philips PulseRelief device which is an electrical stimulator for TENS or EMS.

Electrodes are passive devices serving as an interface between a user's skin and a neurostimulation device.

4.1 Technical characteristics

It is composed of :

    1. Metal target
    1. Rivet
    1. Textile adhesive layer
    1. Carbon layer
    1. Hydrogel layer
    1. Backing sheet

See picture below:

Image /page/4/Picture/12 description: The image shows an exploded view of a multi-layered object. There are six distinct layers labeled with numbers 1 through 6. Layers 1 and 5 have circular features, while layer 2 has a raised circular feature. The layers are arranged in a stack, with layer 1 at the top and layer 6 at the bottom.

5

Proper current distribution is delivered via use of a printed silver pattern.

Axelgaard manufactures both the Philips Self-Adhesive Electrodes and the predicate electrodes K130987, with the same conductive hydrogel (tested for biocompatibility), conductive carbon film, printed silver pattern and electrode carrier liner

5. INDICATION FOR USE

The Philips Self-Adhesive Electrodes are intended for use with the PulseRelief device for applying Transcutaneous Electrical Nerve Stimulation (TENS) and Electrical Muscle Stimulation (EMS).

6. SUMMARY OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE

TopicSelf-Adhesive ElectrodesValuTrode® Neurostimulation Electrodes
510(k) NumberK#K130987
ManufacturerPhilips Consumer LifestyleAxelgaard
Regulation
Number882.1320882.1320
Product CodeGXYGXY
Indication of useThe Philips Self-Adhesive Electrodes
are intended for use with the
PulseRelief device for applying
Transcutaneous Electrical Nerve
Stimulation (TENS) and Electrical
Muscle Stimulation (EMS).ValuTrode®) reusable, self-
adhering, over-the-counter
Neurostimulation
Electrodes are indicated for
use with transcutaneous
electrical stimulation
devices. Some common
types of transcutaneous
stimulation devices
include, but are not limited to,
transepithelial nerve
stimulation (TENS) and
electrical muscle stimulation
(EMS) devices.
Transcutaneous
Neurostimulation Electrodes
are passive devices serving
as an interface
between a user's skin and a
neurostimulation device
Table 2: Substantial Equivalence Comparison Table
TechnologyCutaneous electrode which conducts
an electrical signal from a
neurostimulation device through a
printed silver pattern; which is
dispersed from the wire across a
conductive surface; then transmitted
through the conductive adhesive gel
to the surface of the patient's skinCutaneous electrode which
conducts an electrical signal
from a neurostimulation
device through a printed
silver pattern; which is
dispersed from the wire
across a conductive surface;
then transmitted through the
conductive adhesive gel to
the surface of the patient's
skin
Axelgaard manufactures both the
Philips Self-Adhesive Electrodes and
the predicate electrodes K130987,
with the same conductive hydrogel
(tested for biocompatibility),
conductive carbon film, printed silver
pattern and electrode carrier liner.Axelgaard manufactures both
the Philips Self-Adhesive
Electrodes and the predicate
electrodes K130987, with the
same conductive hydrogel
(tested for biocompatibility),
conductive carbon film,
printed silver pattern and
electrode carrier liner.
Safety and
effectivenessBased on the successful
biocompatibility testing of the skin
contacting surface, the Philips Self-
Adhesive Electrodes are safe and
effective when used as an interface
between a user's skin and the Philips
PulseRelief deviceBased on successful
biocompatibility testing of the
skin contacting conductive
hydrogel, the electrical
performance of the insulated
lead wire components and
electrode current distribution
tests results, the Value Trode
neuro stimulation devices are
safe and effective when used
as an interface between a
user's skin and an approved
neuro stimulation devices
The average
power density
shall not exceed
0.25 watts per
square
centimeter of
electrode
conductive
surface area.The maximum current of the device
is 60mA. The device is current-
controlled, so the current does not
depend on the load. The maximum
voltage is 60V. The size of the
electrodes is 50mmx50mm with an
equal current distribution.
The pulse shape is rectangular, so
the r.m.s. current is identical to the
average current. The worst case
r.m.s. current is in program 1, with
two phases of 90µs at a repetition
rate of 100Hz (10ms repetition
duration), this results in averageThe Axelgaard electrode will
be used with different TENS
devices, which is not the case
for the Philips Self-Adhesive
electrode that is only to be
used with the PulseRelief and
thus guarantee the power
density of maximum of 0.0026
W/cm2 which is below the
maximum value.
current of (2*90µs/10ms)*60mA =
1.08mA. The surface of the
electrodes is 50x50mm = 25cm2.
The current density is
1.08mA/25cm2 = 43µA r.m.s. The
power is the product of the current
and the voltage, so the average
power is 43µA * 60V = 0.0026
W/cm2.
Features/materialThe electrode is composed of:
• Top cover material;
• Connection button;
• Conductive carbon film;
• Conductive hydrogel;
• Electrode carrier liner.The electrode is composed
of:
• Top cover material;
• Connector lead wire or
snap;
• Conductive carbon film;
• Conductive hydrogel;
• Electrode carrier liner.
Size5 x 5 cm² (2in x 2in)Several size including the
same 5x5 cm² (2in x2in)
Principles of
OperationPhilips Self-Adhesive electrode are
intended for use with TENS units as
OTC devices.
Some common type of neuro
stimulation devices include, but are
not limited to, TENS and EMS
devices.
TENS electrodes are passive
devices serving as an interface
between a user's skin and a neuro
stimulation deviceValue Trodes are intended for
use with TENS units as OTC
devices.
Some common type of neuro
stimulation devices include,
but are not limited to, TENS
and EMS devices.
TENS electrodes are passive
devices serving as an
interface between a user's
skin and a neuro stimulation
device
DifferencesPhilips electrode has a metal button
that enables a magnetic clamping
with the Pulse Relief deviceThe ValueTrodes uses either
snap or lead wires to connect
with the TENS.

6

7

7. PERFORMANCE DATA

The following performance data are provided in support of the substantial equivalence determination:

7.1 Biocompatibility testing

The biocompatibility evaluation for the Philips Self-Adhesive Electrodes device was conducted in accordance with the FDA Blue Book Memorandum #G95-1 "Use of International Standard ISO-10993, 'Biological Evaluation of Medical Devices Part 1: Evaluation and Testing," May 1, 1995, and International Standard ISO 10993-1 "Biological Evaluation of Medical Devices -Part 1: Evaluation and Testing Within a Risk Management Process," as recognized by FDA. As dictated by the application and duration of contact with the intact skin, the battery of testing included the following tests:

• Cytotoxicity

8

  • · Sensitization
  • · Irritation

7.2 Other Performance Tests

The Philips Self-Adhesive Electrode is the same as the predicate device, the ValuTrode® Neurostimulation Electrodes from Axelgaard and it is manufactured by Axelgaard. Therefore the tests performed in the Neurostimulation Electrodes applies to the Philips Self-Adhesive Electrode.

1. Electrical & Impedance Tests

The Philips Self-Adhesive Electrode was tested to assure the current is equally distributed. The Philips Self-Adhesive Electrode was also tested for Impedance to assure proper electrical connection to the skin.

2. Adhesion tests

The Philips Self-Adhesive Electrode was tested for initial adhesion force and adhesion force after using multiple times.

3. Connector & Mechanical tests

The TENS PulseRelief has a magnetic surface with the purpose to clamp the Philips Self-Adhesive Electrode. This connection was tested to assure multiple use and also to assure the TENS PulseRelief stay fixed to the Philips Self-Adhesive Electrode during use.

4. Packaging tests

The Philips Self-Adhesive Electrode was tested for storage conditions:

  • The Philips Self-Adhesive Electrode should not be stored at temperatures lower than 41°F (+5°C) or higher than 80.6°F (+27°C).

5. Accelerated Aging

The Philips Self-Adhesive Electrode was tested for accelerate aging in worst storage condition to assure within the expiration date the electrode function as expected.

8. CONCLUSION

:

The performance testing presented above establishes that the device is safe and effective for its intended use. The comparison tabulated above demonstrates that the device is substantially equivalent to the predicate devices.